Antiretroviral News and Research RSS Feed - Antiretroviral News and Research

Project to help those living with HIV launched by Beckman Coulter

Project to help those living with HIV launched by Beckman Coulter

Beckman Coulter Life Sciences is launching an international HIV/AIDS award at the 2016 conference for the African Society for Laboratory Medicine (ASLM) being held in Cape Town, South Africa (December 3 to 8). [More]
Surveys reveal exceptional progress against HIV in Africa

Surveys reveal exceptional progress against HIV in Africa

National surveys in Zimbabwe, Malawi, and Zambia reveal exceptional progress against HIV, with decreasing rates of new infection, stable numbers of people living with HIV, and more than half of all those living with HIV showing viral suppression through use of antiretroviral medication. For those on antiretroviral medication, viral suppression is close to 90 percent. [More]
Liverpool-led research consortium aims to reduce mother-to-child transmission of HIV

Liverpool-led research consortium aims to reduce mother-to-child transmission of HIV

Researchers from the University of Liverpool's Institute of Translational Medicine have been awarded a grant of up to US$ 8.9 million (GBP £5.8m) to lead a multinational research consortium that aims to reduce mother-to-child transmission of HIV. [More]
FIRS calls on governments, health organizations to strengthen response to HIV on World AIDS Day

FIRS calls on governments, health organizations to strengthen response to HIV on World AIDS Day

In recognition of World AIDS Day, held annually on Dec. 1 each year since 1988, the Forum of International Respiratory Societies (FIRS) is calling on governments, health advocates and non-government organizations to strengthen their response to HIV/AIDS. In 2015 AIDS claimed 1.1 million lives. [More]

WHO releases new guidelines on self-testing to improve uptake of HIV diagnosis

In advance of World AIDS Day, the World Health Organization (WHO) has released new guidelines on HIV self-testing to improve access to and uptake of HIV diagnosis. [More]
NIH-supported first HIV vaccine efficacy study begins in South Africa

NIH-supported first HIV vaccine efficacy study begins in South Africa

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. [More]
Scientists develop new technology that sheds light on HIV infection

Scientists develop new technology that sheds light on HIV infection

A group of researchers at the Centre for Genomic Regulation and the Pompeu Fabra University in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and offers a first glance at the expression landscape of the HIV in the human genome. [More]
New antiretroviral treatments show potential to reduce chances of sexual transmission of HIV virus

New antiretroviral treatments show potential to reduce chances of sexual transmission of HIV virus

More than 2 million people got infected by human immunodeficiency virus (HIV) in 2015, being sexual transmission the main channel of infection. [More]
Scientists develop genetically engineered T cells with fusion inhibitor to disrupt HIV's harpoon

Scientists develop genetically engineered T cells with fusion inhibitor to disrupt HIV's harpoon

When HIV attacks a T cell, it attaches itself to the cell's surface and launches a "harpoon" to create an opening to enter and infect the cells. [More]
Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected individuals after they stopped receiving antiretroviral therapy, according to a study published in the New England Journal of Medicine by researchers at the University of Alabama at Birmingham, the National Institutes of Health and the University of Pennsylvania Penn Center for AIDS Research. [More]
Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or functionally cure HIV, according to two related studies from Perelman School of Medicine at the University of Pennsylvania, the University of Alabama at Birmingham, and the National Institutes of Health. [More]
Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV. [More]
Investigational treatment combination improves virologic control in SIV-infected monkeys

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV. [More]
New biologic medication shows promise in treating multi-drug resistant HIV patients

New biologic medication shows promise in treating multi-drug resistant HIV patients

A new biologic medication - the first for HIV - is showing promise in treating patients with multidrug resistance, according to phase 3 research being presented at IDWeek 2016. [More]
Researchers use new gene-editing system to hasten quest to cure HIV+ patients

Researchers use new gene-editing system to hasten quest to cure HIV+ patients

Researchers at UC San Francisco and the academically affiliated Gladstone Institutes have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection. [More]
GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Fungal infection causes around half of AIDS-related deaths, of which there were 1,100,000 in 2015. A first of its kind analysis – ‘Modelling reduction in AIDS deaths’ by the University of Manchester’s Professor David W Denning and published today in Philosophical Transactions of the Royal Society B – suggests that the opportunity to save lives is being missed. [More]
Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

A table-top device that enables medical staff to genetically manipulate a patient's blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multi-million-dollar "clean rooms," making gene therapy more possible for even the poorest of countries. [More]
New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology. [More]
UCSF researchers find active HIV in tissue samples of patients treated with antiretrovirals

UCSF researchers find active HIV in tissue samples of patients treated with antiretrovirals

While successful treatment of HIV with antiretroviral medications leads to undetectable levels of virus in the blood, controls the disease and leads to much longer lifespans, scientists know that HIV continues to reside in tissues. [More]
Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Most women who used an experimental vaginal ring for HIV prevention report that the physical act of sex was largely unaffected by using the product, which is inserted monthly for continuous wear. [More]
Advertisement